Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors. (Q48485483)

11 February 2018

title

Alternative lengthening of telomeres is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors. (English)

1 reference

11 February 2018

author

Marc Remke

14

1 reference

11 February 2018

Jonathan D. Wasserman

object named as

Jonathan Wasserman

9

0 references

Irene L Andrulis

20

object named as

Irene L Andrulis

1 reference

11 February 2018

26

Eric Bouffet

1 reference

11 February 2018

31

Uri Tabori

1 reference

11 February 2018

30

Cynthia Hawkins

1 reference

11 February 2018

24

James T Rutka

1 reference

11 February 2018

author name string

Joshua Mangerel

1

1 reference

11 February 2018

Aryeh Price

2

1 reference

11 February 2018

Pedro Castelo-Branco

3

1 reference

11 February 2018

Jack Brzezinski

4

1 reference

11 February 2018

Pawel Buczkowicz

5

1 reference

11 February 2018

Patricia Rakopoulos

6

1 reference

11 February 2018

Diana Merino

7

1 reference

11 February 2018

Berivan Baskin

8

1 reference

11 February 2018

Matthew Mistry

10

1 reference

11 February 2018

Mark Barszczyk

11

1 reference

11 February 2018

Daniel Picard

12

1 reference

11 February 2018

Stephen Mack

13

1 reference

11 February 2018

Hava Starkman

15

1 reference

11 February 2018

Cynthia Elizabeth

16

1 reference

11 February 2018

Cindy Zhang

17

1 reference

11 February 2018

Noa Alon

18

1 reference

11 February 2018

Jodi Lees

19

1 reference

11 February 2018

Jay S Wunder

21

1 reference

11 February 2018

Nada Jabado

22

1 reference

11 February 2018

Donna L Johnston

23

1 reference

11 February 2018

Peter B Dirks

25

1 reference

11 February 2018

Michael D Taylor

27

1 reference

11 February 2018

Annie Huang

28

1 reference

11 February 2018

David Malkin

29

1 reference

11 February 2018

publication date

15 October 2014

1 reference

11 February 2018

published in

Acta Neuropathologica

1 reference

11 February 2018

volume

128

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

853-862

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1007/s00401-014-1348-1

exact match

0 references

cites work

The alternative lengthening of telomere phenotype is significantly associated with loss of ATRX expression in high-grade pediatric and adult astrocytomas: a multi-institutional study of 214 astrocytomas

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Human telomeres contain at least three types of G-rich repeat distributed non-randomly

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Telomere length measurement-caveats and a critical assessment of the available technologies and tools

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Homologous recombination in human telomerase‐positive and ALT cells occurs with the same frequency

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

High expression of BMP pathway genes distinguishes a subset of atypical teratoid/rhabdoid tumors associated with shorter survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Methylation of the TERT promoter and risk stratification of childhood brain tumours: an integrative genomic and molecular study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Alternative lengthening of telomeres: models, mechanisms and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Association of mutant TP53 with alternative lengthening of telomeres and favorable prognosis in glioma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Treatment Options for Medulloblastoma and CNS Primitive Neuroectodermal Tumor (PNET)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Telomere maintenance in childhood primitive neuroectodermal brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Alternative Lengthening of Telomeres is characterized by reduced compaction of telomeric chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Altered telomeres in tumors with ATRX and DAXX mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Prevalence of the alternative lengthening of telomeres telomere maintenance mechanism in human cancer subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

TERT promoter mutations in familial and sporadic melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Frequent ATRX, CIC, FUBP1 and IDH1 mutations refine the classification of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Cross-species genomics matches driver mutations and cell compartments to model ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Paediatric and adult malignant glioma: close relatives or distant cousins?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Whole-exome sequencing identifies ATRX mutation as a key molecular determinant in lower-grade glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Molecular diagnostics in paediatric glial tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Distribution of TERT promoter mutations in pediatric and adult tumors of the nervous system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Frequent ATRX mutations and loss of expression in adult diffuse astrocytic tumors carrying IDH1/IDH2 and TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Epigenomic alterations define lethal CIMP-positive ependymomas of infancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Telomeric armor: the layers of end protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

C11orf95-RELA fusions drive oncogenic NF-κB signalling in ependymoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Expression of p53 and prognosis in children with malignant gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Genome sequencing of pediatric medulloblastoma links catastrophic DNA rearrangements with TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

TERT promoter mutations are highly recurrent in SHH subgroup medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Pediatric high-grade glioma: molecular genetic clues for innovative therapeutic approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Children are not just little adults: recent advances in understanding of diffuse intrinsic pontine glioma biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Excessive genomic DNA copy number variation in the Li-Fraumeni cancer predisposition syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

TP53 alterations determine clinical subgroups and survival of patients with choroid plexus tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

The role of telomere maintenance in the spontaneous growth arrest of pediatric low-grade gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Telomerase promoter mutations in cancer: an emerging molecular biomarker?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Telomerase inhibition induces acute ATM-dependent growth arrest in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

Subgroup-specific prognostic implications of TP53 mutation in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-014-1348-1

10.1007/S00401-014-1348-1

21 January 2018

Identifiers

DOI

1 reference

11 February 2018

PubMed ID

25315281

1 reference

11 February 2018